Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 4—April 2025
Dispatch

Molecular Epidemiology of Oropouche Virus, Ceará State, Brazil, 2024

Shirlene T.S. de Lima1, Xinyi Hua1, Ingra M. Claro1, Carlos Garcia Filho, Leda M. Simões Mello, Ronaldo de Jesus, Amanda Bleichrodt, Ana Maria P.C. Maia, Ana Carolina B.M. Máximo, Karene F. Cavalcante, Antônio Carlos L. Firmino, Larissa M.F. Duarte, Luiz Osvaldo R. da Silva, Andre R.R. Freitas, Isaac Chun-Hai Fung, Gerardo Chowell, Pritesh Lalwani, Luciano P.G. Cavalcanti, Camila M. Romano, José Luiz Proenca-Modena, and William M. de SouzaComments to Author 
Author affiliation: University of Kentucky, Lexington, Kentucky, USA (S.T.S. de Lima, X. Hua, I.M. Claro, W.M. de Souza); Laboratório Central de Saúde Pública do Ceará, Fortaleza, Brazil (S.T.S. de Lima, L.M. Simões Mello, A.C.B.M. Máximo, K.F. Cavalcante, A.C.L. Firmino, L.M.F. Duarte); Universidade Estadual de Campinas, Campinas, Brazil (S.T.S. de Lima, J.L. Proenca-Modena); Universidade de Fortaleza, Fortaleza (C.G. Filho); Universidade Federal de Minas Gerais, Belo Horizonte, Brazil (R. de Jesus, L.O.R. da Silva); Georgia State University, Atlanta, Georgia, USA (A. Bleichrodt, G. Chowell, L.P.G. Cavalcanti); Universidade Federal do Ceará, Fortaleza (A.M.P.C. Maia); Faculdade São Leopoldo Mandic, São Paulo (A.R.R. Freitas); Georgia Southern University, Statesboro, Georgia, USA (I.C.-H. Fung); Fiocruz Amazônia, Manaus, Brazil (P. Lalwani); University of São Paulo, São Paulo (C.M. Romano)

Main Article

Figure 1

Incidence of laboratory-confirmed Oropouche fever, dengue, and chikungunya cases in study of molecular epidemiology of OROV, Ceará state, Brazil, January–December 2024. Incidence is shown per epidemiologic week at state-level from epidemiologic week 1 (December 31, 2023–January 6, 2024) to epidemiologic week 52 of 2024 (December 22–28, 2024). CHIKV, chikungunya virus; DENV, dengue virus; OROV, Oropouche virus.

Figure 1. Incidence of laboratory-confirmed Oropouche fever, dengue, and chikungunya cases in study of molecular epidemiology of OROV, Ceará state, Brazil, January–December 2024. Incidence is shown per epidemiologic week at state-level from epidemiologic week 1 (December 31, 2023–January 6, 2024) to epidemiologic week 52 of 2024 (December 22–28, 2024). CHIKV, chikungunya virus; DENV, dengue virus; OROV, Oropouche virus.

Main Article

1These authors contributed equally to this article.

Page created: March 12, 2025
Page updated: March 12, 2025
Page reviewed: March 12, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external